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trained to think of structures in this way from the mo-RNA as Multitude/RNA as One
tionless, indispensable polychromes that illustrate the
conclusions of structural biologists’ experiments. How-
ever, the huge energetic penalty rendered for unpaired
charges implies that RNA molecules are always electri-In the configurations formed by RNA and its ions there
cally neutral. Therefore, RNAs are inevitably accompa-are structural possibilities not yet realized; some are
hinted at in new work on the binding of an amino acid nied by ions, about one ionic charge per nucleotide
analog. phosphate. So, for many purposes, RNA is better illus-
trated as a fluctuating crowd of particles. Magnesium
is more influential than potassium because the electricalRNA surely means different things to different biologists,
neutrality generated by localizing a single magnesiumbut molecules are usually thought of as unitary objects,
as explicit as a mountain or a building. We have been ion frees two potassium ions, yielding an entropic ad-
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Figure 1. Secondary Structure of SHR1.48
RNA and RT Mapping of Modification Site
vantage. Even when ions cannot be seen, as they often divalent ion. These ions are a group of transition metals
that have extremely slow exchange rates for bound wa-cannot in crystallographic reconstructions, a crowd of
neutralizing divalents and monovalents is still there, run- ter and other ligands. Specifically, the Burke group se-
lected an RNA that will use Ni2 (with moderately slowedning in channels defined by the electric potential of the
RNA [1]. Although their identities may change, electri- exchange) and Pt2 (with very slow exchange) to bind
a small molecule ligand, biocytin, (biocytin is biotinoyl-cally bound ions are “real” parts of the molecule, and
their presence can be detected by techniques such as lysine) to RNA. Ni2 and Pt2 would be expected to
slowly give up their affinity for water to join an RNAequilibrium dialysis. Ions’ preference for the folded state
is a major incentive for nucleic acid polymers to form structure and then slowly release once localized in an
RNA-biocytin site. These properties were readily ob-compact native structures, as indicated by the results
from the electrostatic calculations of Misra and Dra- served: formation of RNA:Pt:biocytin is still improving
at 18 hr at 52C (pH 7), which surely must strain theper [2].
Associated ions are therefore essential for structural stability of the RNA at the binding site. Similarly, both
Ni2 and Pt2 complexes survived two ethanol precipita-stability and are also essential to RNA function, particu-
larly in some catalytic RNA reactions. Though once seen tions and exhibited half-lives of hours on subsequent
incubation at 25 without substrates or divalent ions.as exclusively metalloenzymes [3, 4], ribozymes are in
fact a mixed bag. Some RNA active sites exploit the The authors selected the RNA with the goal of isolating
a molecule that reacted with the lysine moiety of biocytinchemistry of immobilized ions, like the group I self-splic-
ing RNA [5], whereas others, like the hairpin ribozyme, to emulate the normal reaction of aminoacyl-tRNA syn-
thetase proteins in fixing amino acids to RNA. Whathave metal-free mechanisms [6]. Regardless, ribozymes
certainly draw attention to the requirement for precisely emerged from three different selection experiments was
a molecule containing a 37 nucleotide three-helix junc-located RNA-associated ions. When a chemical reaction
includes an ion, its bound state must be exquisitely tion (SHR1 RNA) with an unusually stringently conserved
structure. Nucleic acid-metal-biocytin coordination is,specific (or a specific site and orientation must at least
be attained relatively frequently). This requirement unexpectedly, disrupted by variation of almost any of
the nucleotides in the binding site. A unique role formakes an infrequent circumstance disproportionately
important: occasionally, a folded RNA contains such a nickel emerged because it was one of a cocktail of nine
divalents added to the selection, fishing for RNA reac-deep negative electrostatic hole that very strongly
bound water will be stripped from a bound ion, permit- tions that exploited chemistries unique to individual met-
als, so-called “Cheshire catalysts” [3]. In this sense, theting better charge-charge interactions between ion and
RNA. During such infrequent occurrences, RNA ligands strategy succeeded, though organic chemistry rather
than bioinorganic coordination was the initial goal.(such as phosphate oxygens or guanine N7) enter the
ions’ inner coordination sphere, and the ions become a Now that Hati and colleagues have shown how to do
it, one can easily envision generalizing their strategy tolong-lived part of the RNA tertiary structure. Therefore,
despite the fact that most ions are a part of a fluctuating select for self-assembling RNA nanostructures. Nano-
RNA is an emerging field pioneered by Luc Jaeger andRNA atmosphere, there is a population of key fixed ions
confined by unusual electrostatic barriers and chemical Eric Westhof [8], who use tetraloop-receptor interac-
tions to build RNA structures, and extended by otherscoordination.
In the November issue of Chemistry & Biology, San- [9] using kissing loops as the linking element. Given that
the ultimate purpose of this work is to establish meanschita Hati et al. [7] in Don Burke’s laboratory at Indiana
University set out to extensively explore this phenome- to controllably assemble RNAs into larger functional ob-
jects, one would like to be able to either select for affinitynon by exploiting a type of extraordinarily localizable
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like Ni2. The simultaneous presence of the usual mono- Developmental Biology
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they will aid general RNA folding without effectively Boulder, Colorado 80302
competing with slow exchanging ion at its rare binding
sites. When molecules have been selected that stably
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horizontal gene transfer in bacteria. Failure or inabilityRNA Sex
to perform recombination may lead to serious draw-
backs. A case in point are animal mitochondria, which
have resorted to a number of complicated mechanisms
to compensate for deleterious effects of slowly accumu-Recombination of genetic information is a major driv-
lated point mutations in the mitochondrial genome [3].ing force in evolution, today catalyzed by protein en-
Recombination at the level of RNA has been reportedzymes. In this issue of Chemistry & Biology, a paper
for viruses [4]. Splicing of mRNAs to generate a varietyby Riley and Lehman [1] demonstrates that RNA can
of different exons from a pre-mRNA is a mechanismperform general recombination of RNA strands, thus
bearing characteristics akin to recombination, althoughsupporting the scenario of a prebiotic RNA world.
the newly generated sequence information is not
handed down to the next generation. RNA from certain
Advances in evolution have for some time been viewed organisms is capable of performing the splicing reaction
by many as a process of continuing occurrence of minor without the help of cofactors, protein or other, by se-
mutations under the constant scrutiny of selection pres- quential execution of a cleavage and a ligation reaction.
sure, blocking the amplification of deleterious mutations Incidentally, these properties present the first reported
and favoring a few punctual improvements. Besides the catalytic activities of RNA, the discovery of which, by
apparent painful slowness of such a process, mathemat- Cech and coworkers in 1982 [5], was later awarded the
ical models have clearly indicated that populations un- Nobel price.
der a certain number of individuals would suffer a contin- In their paper “Generalized RNA-Directed Recombina-
uous loss of fitness from mildly deleterious mutations tion of RNA,” Riley and Lehman [1] make use of the
rather than producing a series of champions [2]. Sexual catalytic properties of such introns to catalyze a reaction
recombination offers a way out, since “good” mutations resembling a metathesis reaction:
can also arise in, and propagate from, strains with a
number of deleterious mutations. Moreover, rather than RNA
catalysiseffecting single point mutations, recombination can gen-
erate, by error or design, sequence changes to a much
larger extent. Such events enlarge the complexity of a A-B  C-D ←→ A-D  C-B, (1)given sequence pool by leaps and bounds in com-
parison.
All but a few of today’s replicating entities try to im- where A-B is a first RNA comprising a head and a tail
part, and C-D is a second RNA composed similarly.prove their evolutionary flexibility by employing recom-
bination, sometimes even by borrowing genetic informa- Based on previous observations by several other
groups, the authors have turned, through proficient mo-tion from outside their species, as in the case of
